News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16,396 Results
Type
Article (2372)
Company Profile (1)
Press Release (14023)
Section
Business (3170)
Career Advice (16)
Deals (401)
Drug Delivery (4)
Drug Development (4606)
Employer Resources (2)
FDA (379)
Job Trends (276)
News (7679)
Policy (618)
Tag
Academia (242)
Adcomms (7)
Alliances (990)
ALS (6)
Alzheimer's disease (921)
Approvals (372)
Artificial intelligence (5)
Bankruptcy (4)
Best Places to Work (257)
Cancer (13)
Career advice (15)
Cell therapy (16)
Clinical research (3271)
Collaboration (21)
COVID-19 (93)
Data (101)
Depression (11)
Diabetes (7)
Diagnostics (134)
Drug discovery (7)
Earnings (1146)
Events (2269)
Executive appointments (4)
FDA (433)
Funding (23)
Gene therapy (18)
GLP-1 (31)
Government (104)
Healthcare (503)
Huntington's disease (14)
Infectious disease (94)
Intellectual property (5)
IPO (164)
Job creations (32)
Job search strategy (14)
Layoffs (17)
Legal (52)
Lung cancer (5)
Medical device (235)
Medtech (235)
Mergers & acquisitions (241)
Metabolic disorders (23)
Multiple sclerosis (11)
Neurodegenerative disease (26)
Neuropsychiatric disorders (11)
Neuroscience (1041)
NextGen: Class of 2025 (170)
Non-profit (162)
Northern California (68)
Obesity (11)
Opinion (10)
Parkinson's disease (45)
Patents (6)
People (814)
Phase I (874)
Phase II (1727)
Phase III (1083)
Pipeline (30)
Postmarket research (86)
Preclinical (407)
Psychedelics (7)
Radiopharmaceuticals (6)
Rare diseases (24)
Real estate (53)
Regulatory (555)
Research institute (159)
Schizophrenia (38)
Series A (4)
Southern California (58)
Startups (80)
United States (763)
Vaccines (20)
Weight loss (5)
Date
Today (8)
Last 7 days (29)
Last 30 days (103)
Last 365 days (1414)
2025 (196)
2024 (1428)
2023 (1463)
2022 (1769)
2021 (1624)
2020 (1216)
2019 (1202)
2018 (894)
2017 (777)
2016 (883)
2015 (1046)
2014 (741)
2013 (497)
2012 (433)
2011 (417)
2010 (429)
Location
Africa (16)
Asia (1046)
Australia (321)
California (146)
Canada (57)
Connecticut (8)
Europe (2399)
Florida (66)
Georgia (5)
Illinois (16)
Indiana (22)
Japan (20)
Kansas (6)
Maryland (35)
Massachusetts (154)
Missouri (5)
Nevada (10)
New Jersey (58)
New York (148)
North Carolina (7)
Northern California (68)
Ohio (9)
Pennsylvania (29)
South America (26)
Southern California (58)
Texas (33)
Washington State (18)
16,396 Results for "umecrine cognition".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cognition Therapeutics Publishes Research Supporting the Potential of Zervimesine in Dry AMD
February 27, 2025
·
7 min read
Press Releases
Cognition’s Positive Phase 2 ‘SHIMMER’ Study of Zervimesine (CT1812) in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at ILBDC
January 30, 2025
·
9 min read
Press Releases
Cognition Therapeutics’ Analysis Correlates Biomarker Changes with Cognitive Benefit in Alzheimer’s Population
November 25, 2024
·
9 min read
Press Releases
Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences
January 9, 2025
·
5 min read
Press Releases
Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit
February 25, 2025
·
6 min read
Press Releases
Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)
January 30, 2025
·
1 min read
Press Releases
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)
February 21, 2025
·
6 min read
Press Releases
Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
February 26, 2025
·
7 min read
Press Releases
Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease
February 13, 2025
·
3 min read
Press Releases
Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL
January 15, 2025
·
6 min read
1 of 1,640
Next
